DRYGIN DENIS (Chief Scientific Officer) purchased 23.31K shares of REGULUS THERAPEUTICS INC. on the open market
Open‑market purchase worth $5.4K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/7/2022ACC: 0001209191-22-007506
Officer· Chief Scientific Officer
Since Aug 2020
+23.31K
Net shares
Net buyer
$5.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
23.31K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+23.31K
Price / share
$0.23
Trade value
$5.36K
% of position
New position
2/4/2022
0.00→23.31K
Total
Net shares
+23.31K
Net value
$5.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2022 | P · Purchase | +23.31K | $0.23 | $5.36K | New position | 0.00 | 23.31K |
| Total | +23.31K | $5.36K | ||||||
Derivative Transactions0
No derivative transactions reported